Antibacterial, Anti-inflammatory and Antiviral Series

Cat.No. Product Name CAS Inquiry
PAP-0052 Adefovir dipivoxil 142340-99-6 Inquiry
PAP-0040 AMIKACIN SULFATE 39831-55-5 Inquiry
PAP-0055 Azithromycin 117772-70-0 Inquiry
PAP-0068 Bromfenac sodium 91714-94-2 Inquiry
PAP-0067 Cefoxitin Sodium 33564-30-6 Inquiry
PAP-0096 Ceftriaxone Sodium Sterile 104376-79-6 Inquiry
PAP-0066 Cefuroxime Sodium 56238-63-2 Inquiry
PAP-0062 Ciprofloxacin HCI 93107-08-5 Inquiry
PAP-0045 DOXYCYCLINE HYCLATE 24390-14-5 Inquiry
PAP-0054 Enythromycin 114-07-8 Inquiry


Antibacterial, anti-inflammatory, and antiviral drugs are commonly used clinically. However, with the spread and evolution of drug resistance, the efficacy of these drugs, especially antibacterial and antiviral drugs, is declining. At present, there is no effective means to deal with the problem of drug resistance clinically, and the development of new drugs is urgently needed.

CD Formulation provides a variety of Antibacterial, Anti-inflammatory and Antiviral Series APIs, and offers customized services according to customer needs.

Antibacterial Series

Antibacterial series can be divided into antifungal drugs and antibacterial drugs. Common antibacterial drugs include β-lactams, aminoglycosides, macrolides, quinolones, tetracyclines, and glycopeptides. Drugs for the treatment of systemic fungal infections include amphotericin B, azole derivatives, echinocandins, and flucytosine.

Antibacterial Mechanisms of DrugsAntibacterial Mechanisms of Drugs

Anti-inflammatory Series

Anti-inflammatory drugs include steroidal anti-inflammatory drugs and non-steroidal anti-inflammatory drugs. It exerts antipyretic, analgesic and anti-inflammatory effects by inhibiting the synthesis of prostaglandins, inhibiting the aggregation of white blood cells, reducing the formation of bradykinin, and inhibiting the aggregation of platelets.

Antiviral Series

At present, viral diseases with high morbidity and low cure rate such as AIDS and viral hepatitis are still spreading around the world, and respiratory viruses such as influenza virus and coronavirus continue to mutate. The development of safe and effective antiviral drugs has become an important means of dealing with viral diseases. There are many ways to resist viral infection, such as directly inhibiting or killing viruses, interfering with virus adsorption, preventing viruses from penetrating cells, inhibiting virus biosynthesis, inhibiting virus release, or enhancing host anti-virus capabilities.

Online Inquiry
Please note: Our products and services are not intended to be used directly in diagnostic or therapeutic procedures.
Enter your email here to subscribe.

Easy access to products and services you need from our library via powerful searching tools.

Copyright © CD Formulation. All Rights Reserved.  Privacy Policy | Cookie Policy